Thrivent Financial For Lutherans Acadia Pharmaceuticals Inc Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$14.62 - $18.42 $48,874 - $61,578	-3,343 Reduced 4.1%	78,292 $1.27 Million
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $423,224 - $734,159	23,790 Added 41.13%	81,635 $1.51 Million
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $974,956 - $1.49 Million	46,918 Added 429.38%	57,845 $1.81 Million
Q3 2023 Nov 14, 2023	SELL	$20.84 - $33.47 $4.08 Million - $6.55 Million	-195,729 Reduced 94.71%	10,927 $228,000
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $1.07 Million - $1.54 Million	-59,988 Reduced 22.5%	206,656 $4.95 Million
Q1 2023 May 17, 2023	BUY	$16.32 - $20.92 $3.01 Million - $3.86 Million	184,505 Added 224.63%	266,644 $5.02 Million
Q4 2022 Feb 08, 2023	SELL	$14.2 - $18.63 $1.24 Million - $1.63 Million	-87,367 Reduced 51.54%	82,139 $1.31 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $2.39 Million - $3.1 Million	169,506 New	169,506 $2.77 Million
Q1 2022 May 13, 2022	SELL	$20.94 - $27.5 $7.29 Million - $9.57 Million	-348,107 Closed	0 $0
Q4 2021 Feb 16, 2022	SELL	$16.79 - $27.09 $6.1 Million - $9.84 Million	-363,060 Reduced 51.05%	348,107 $8.13 Million
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $163,780 - $257,087	-10,379 Reduced 1.44%	711,167 $11.8 Million
Q2 2021 Aug 19, 2021	SELL	$19.4 - $27.42 $3.21 Million - $4.53 Million	-165,367 Reduced 18.65%	721,546 $17.6 Million
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $2.42 Million - $5.33 Million	96,836 Added 12.26%	886,913 $22.9 Million
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $612,522 - $847,590	14,925 Added 1.93%	790,077 $42.2 Million
Q3 2020 Nov 10, 2020	BUY	$36.42 - $57.0 $28.2 Million - $44.2 Million	775,152 New	775,152 $32 Million

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account